New York, November 22, 2017 – Jibrel Network, a Switzerland-based Public Limited Company (AG) who specialize in blockchain implementations for Banks and Non-Bank Financial Institutions (NBFIs), today announced the launch of their first straight-to-consumer product, the jWallet.
New York, New York – November 17, 2017 – Jibrel Network recently announced the successful completion of their token presale, during which US $3,219,299 was raised and 19,985,292.57 Jibrel Network Tokens (JNT) were sold.
Xeltis, an Eindhoven, The Netherlands- and Zurich, Switzerland-based clinical-stage medical device company advancing a restorative approach in heart valve therapy, completed a €45 million ($52m) Series C financing.
NousCom, a Basel, Switzerland–based oncology company, closed its €42m Series B funding round.
The Centre for Citizenship, Enterprise and Governance, a British not-for-profit and university spin-out and world’s leading think-tank on the movement of value, has named the Swiss-based legal cryptocurrency advisor Dianne Schepers LL.M. MBA as Chair of the CCEG Advisory Board.
Eidoo, a Chiasso, Switzerland-based developer of a mobile app for iOS and Android that leverages the blockchain in one single user-friendly environment, raised $27.9M in an ICO.
CorFlow Therapeutics AG, a Baar, Switzerland-based completed the CHF 2.6M first close of its seed+ financing round.
ADC Therapeutics (ADCT), a Lausanne, Switzerland-based oncology drug discovery and development company, raised $200m in funding.
Capital Dynamics, an independent global asset manager, closed its latest mid-market co-investment fund, at $383m.
Lunaphore Technologies SA, a Lausanne, Switzerland-based medtech company developing a next-generation technology for cancer tissue diagnostics, closed a CHF6M second financing round.
Magos AI, a Swiss based startup that is building a blockchain-based prediction software, announced that its Initial Coin Offering (ICO) is coming to an end, with about a week left.
15/09/2017 – Magos AI, the first ever blockchain-based prediction software, has already gathered almost 3000 ETH in its Initial Coin Offering (ICO).
Sophia Genetics, a Lausanne, Switzerland-based data-driven medicine company, closed a $30m Series D funding round.
Amal Therapeutics, a Geneva, Switzerland-based biotech startup developing novel, peptide-based therapeutic cancer vaccines, raised €8M in first closing of Series B funding round.
Everyday, we hear experts saying that Artificial Intelligence is going to transform the world we live in, the way we work, we buy products, spend our spare time, etc., thanks to its unbelievable learning capabilities.